Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ProScript licenses cell cycle regulation technology from Harvard Medical School

April 22, 1997

ImmunoGen's novel anticancer agent eradicates a human cancer in mice

April 22, 1997

Yamanouchi describes potent and selective steroid 17,20 lyase inhibitor

April 22, 1997

Princeton and Lilly disclose nonclassical antifolates

April 22, 1997

Alfacell elucidates action of Onconase

April 22, 1997

PLC-inhibitory peptides from Kyowa Hakko

April 22, 1997

Inflazyme licences anticancer drugs

April 21, 1997

Antimetastatic activity of Neovastat reported at AACR meeting

April 21, 1997

Antitumor/antibacterial agent isolated by Microbial Chemistry Research Foundation

April 21, 1997

Mercian discloses novel anthracycline antibiotics

April 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...